Roche is a global biopharmaceutical company, a leading developer of innovative medicines for cancer and rare diseases.
About the company
The company sought to strengthen public and governmental awareness of breast cancer challenges in Russia, as well as to secure the position of its innovative cancer medicines in the healthcare system.
Client’s request:
Our results:
The medicines have been retained in the Essential Medicines List (EML).
01
Patient access to treatment has been granted.
02
The client’s market position in Russia has been secured.
03
Our solution
Key focus areas
01
- We analyzed the regulatory risks arising from the reviewed circulation frameworks for cancer medicines, and proposed a position aligned with priorities set by public policy and pharmaceutical supply system.
Regulatory Risk Assessment and Positioning
03
- A targeted GR campaign was designed and deployed to establish a meaningful dialogue with public authorities and promote the social significance of company’s innovative medicines.
Development and Implementation of Comprehensive GR Campaign
02
- Key stakeholder mapping, including the Ministry of Health and the Government of the Russian Federation, research or expert organizations, and NGOs.
Stakeholder Mapping
© 2015 — 2026 Baikal Lobridge.
All rights reserved.
All rights reserved.
ООО «БКГ»
ОГРН 1157746465667 | ИНН 7727176391 | КПП 770301001
123056, Россия, г. Москва, ул. Большая Грузинская 30А, стр. 1, БЦ «Грузинка 30»
ОГРН 1157746465667 | ИНН 7727176391 | КПП 770301001
123056, Россия, г. Москва, ул. Большая Грузинская 30А, стр. 1, БЦ «Грузинка 30»
Submit a request and our specialists will contact you for all the details.
Contact Baikal Lobridge®
Submit a request and our specialists will contact you for all the details.
Contact Baikal Lobridge®
